中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2015年
41期
6633-6637
,共5页
干细胞%肿瘤干细胞%胶质瘤干细胞%CmiRNA%miR-486%CD133+胶质瘤细胞%CD133-胶质瘤细胞%增殖%凋亡%细胞周期
榦細胞%腫瘤榦細胞%膠質瘤榦細胞%CmiRNA%miR-486%CD133+膠質瘤細胞%CD133-膠質瘤細胞%增殖%凋亡%細胞週期
간세포%종류간세포%효질류간세포%CmiRNA%miR-486%CD133+효질류세포%CD133-효질류세포%증식%조망%세포주기
Brain Neoplasms%Glioma%MicroRNAs%Cel Cycle%Tissue Engineering
背景:既往研究发现,miR-486在胶质瘤干细胞(CD133+)中的表达水平显著低于其在胶质瘤非干细胞(CD133-)中的表达水平,但是miR-486对CD133+细胞的影响尚不明确。目的:探索miR-486对CD133+细胞的作用。方法:利用流式细胞分选将 U87胶质瘤细胞中分为 CD133+和 CD133-细胞。通过脂质体转染构建 miR-486过表达的胶质瘤干细胞。结果与结论:流式细胞分选和纯化获得高比率的CD133+胶质瘤干细胞。实时反转录PCR检测发现miR-486在CD133+胶质瘤干细胞的表达水平比CD133-胶质瘤细胞明显下降。脂质体转染成功构建miR-486过表达的胶质瘤干细胞,体外实验发现miR-486高表达抑制胶质瘤干细胞的增殖,将其阻滞于G1/S期,并促进凋亡。提示miR-486对胶质瘤干细胞具有抑制作用。
揹景:既往研究髮現,miR-486在膠質瘤榦細胞(CD133+)中的錶達水平顯著低于其在膠質瘤非榦細胞(CD133-)中的錶達水平,但是miR-486對CD133+細胞的影響尚不明確。目的:探索miR-486對CD133+細胞的作用。方法:利用流式細胞分選將 U87膠質瘤細胞中分為 CD133+和 CD133-細胞。通過脂質體轉染構建 miR-486過錶達的膠質瘤榦細胞。結果與結論:流式細胞分選和純化穫得高比率的CD133+膠質瘤榦細胞。實時反轉錄PCR檢測髮現miR-486在CD133+膠質瘤榦細胞的錶達水平比CD133-膠質瘤細胞明顯下降。脂質體轉染成功構建miR-486過錶達的膠質瘤榦細胞,體外實驗髮現miR-486高錶達抑製膠質瘤榦細胞的增殖,將其阻滯于G1/S期,併促進凋亡。提示miR-486對膠質瘤榦細胞具有抑製作用。
배경:기왕연구발현,miR-486재효질류간세포(CD133+)중적표체수평현저저우기재효질류비간세포(CD133-)중적표체수평,단시miR-486대CD133+세포적영향상불명학。목적:탐색miR-486대CD133+세포적작용。방법:이용류식세포분선장 U87효질류세포중분위 CD133+화 CD133-세포。통과지질체전염구건 miR-486과표체적효질류간세포。결과여결론:류식세포분선화순화획득고비솔적CD133+효질류간세포。실시반전록PCR검측발현miR-486재CD133+효질류간세포적표체수평비CD133-효질류세포명현하강。지질체전염성공구건miR-486과표체적효질류간세포,체외실험발현miR-486고표체억제효질류간세포적증식,장기조체우G1/S기,병촉진조망。제시miR-486대효질류간세포구유억제작용。
BACKGROUND:Previous studies have found that the expression level of miR-486 in glioma stem cels (CD133+) is significantly down-regulated compared with that in glioma non-stem cels (CD133-), but the effect of down-regulation of miR-486 on CD133+ cels remains unclear . OBJECTIVE: To explore the effect of miR-486 on CD133+ cels. METHODS:CD133+ glioma stem cels and CD133- glioma cels were separated from U87 cels by flow cytometer. miR-486 overexpression glioma stem cels were constructed by lipofection transfection. RESULTS AND CONCLUSION:After sorting and purification, the content of the CD133+ fraction was enriched up to 83.5%. The expression level of miR-468 in CD133+ glioma stem cels was obviously down-regulated compared with that in CD133- glioma cels. CD133+ glioma stem cels overexpressing miR-486 were fabricated successfuly. Results from in vitro experiments showed that miR-486 overexpression could dramaticaly decrease the proliferation of glioma stem cels, induce a cel cycle arrest in G1/S phase for CD133+ glioma stem cels and promote cel apoptosis. These findings suggest that miR-486 can be a suppressor of glioma stem cels, which offers a novel potential therapeutic target for glioma stem cels and human glioma.